- Home
- ESP vs CRVO Comparison
ESP vs CRVO Comparison
Compare ESP & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESP
- CRVO
- Stock Information
- Founded
- ESP 1928
- CRVO 2001
- Country
- ESP United States
- CRVO United States
- Employees
- ESP N/A
- CRVO N/A
- Industry
- ESP Industrial Machinery/Components
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- ESP Technology
- CRVO Health Care
- Exchange
- ESP Nasdaq
- CRVO Nasdaq
- Market Cap
- ESP 84.1M
- CRVO 95.4M
- IPO Year
- ESP N/A
- CRVO N/A
- Fundamental
- Price
- ESP $27.30
- CRVO $9.11
- Analyst Decision
- ESP
- CRVO Strong Buy
- Analyst Count
- ESP 0
- CRVO 8
- Target Price
- ESP N/A
- CRVO $25.43
- AVG Volume (30 Days)
- ESP 13.6K
- CRVO 13.7M
- Earning Date
- ESP 05-12-2025
- CRVO 03-17-2025
- Dividend Yield
- ESP 3.67%
- CRVO N/A
- EPS Growth
- ESP 31.14
- CRVO N/A
- EPS
- ESP 2.45
- CRVO N/A
- Revenue
- ESP $43,917,522.00
- CRVO $9,737,974.00
- Revenue This Year
- ESP N/A
- CRVO N/A
- Revenue Next Year
- ESP N/A
- CRVO N/A
- P/E Ratio
- ESP $11.12
- CRVO N/A
- Revenue Growth
- ESP 18.62
- CRVO 36.29
- 52 Week Low
- ESP $20.20
- CRVO $1.80
- 52 Week High
- ESP $33.00
- CRVO $25.92
- Technical
- Relative Strength Index (RSI)
- ESP 54.27
- CRVO 59.21
- Support Level
- ESP $26.63
- CRVO $7.13
- Resistance Level
- ESP $27.75
- CRVO $10.72
- Average True Range (ATR)
- ESP 0.60
- CRVO 2.56
- MACD
- ESP 0.17
- CRVO -0.02
- Stochastic Oscillator
- ESP 76.44
- CRVO 45.98
About ESP Espey Mfg. & Electronics Corp.
Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.